Small cell transformation of non‐small cell lung cancer under immunotherapy: Case series and literature review

Código QR

Small cell transformation of non‐small cell lung cancer under immunotherapy: Case series and literature review

Abstract In advanced lung cancer treatment, immunotherapy provides durable responses in some patients. However, other patients experience progressive disease and the resistance mechanisms to immunotherapy have yet been fully elucidated. Small cell transformation of non‐small cell lung cancer (NSCLC)...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Takuma Imakita, Kohei Fujita, Osamu Kanai, Misato Okamura, Masayuki Hashimoto, Koichi Nakatani, Satoru Sawai, Tadashi Mio
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	immunotherapy non‐small cell lung cancer rebiopsy small cell transformation Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/898c28b337844146befb3de01718af18
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Immunotherapy in patients with non-small cell lung cancer with ECOG PS 2
por: Damian Mojsak, et al.
Publicado: (2021)

Cancer Stem Cell-Like Circulating Tumor Cells Are Prognostic in Non-Small Cell Lung Cancer
por: Eva Obermayr, et al.
Publicado: (2021)

Potential of Stem Cells and CART as a Potential Polytherapy for Small Cell Lung Cancer
por: Evgenii Skurikhin, et al.
Publicado: (2021)

Systematic review of sequencing of ALK inhibitors in ALK-positive non-small-cell lung cancer
por: Barrows SM, et al.
Publicado: (2019)

ANTIBODIES TO BENZO[A]PYRENE IN SERUM OF PATIENTS WITH NON-SMALL CELL LUNG CANCER
por: E. G. Polenok, et al.
Publicado: (2012)

Immunotherapy and Radioimmunotherapy for Desmoplastic Small Round Cell Tumor
por: Madelyn Espinosa-Cotton, et al.
Publicado: (2021)

Chemo-Sensitization of CD133+ Cancer Stem Cell Enhances the Effect of Mesenchymal Stem Cell Expressing TRAIL in Non-Small Cell Lung Cancer Cell Lines
por: Kamal Shaik Fakiruddin, et al.
Publicado: (2021)

Prospects for the development of adjuvant therapy for non-small cell lung cancer
por: K. K. Laktionov, et al.
Publicado: (2020)

Oligometastatic non-small-cell lung cancer: current treatment strategies
por: Richard PJ, et al.
Publicado: (2016)

Clinical utility of ramucirumab in non-small-cell lung cancer
por: Uprety D
Publicado: (2019)

Extrapulmonary small cell carcinoma. Literature review
por: Nadezhda F. Orel, et al.
Publicado: (2021)

Tumor Lysis Syndrome following a Single Dose of Nivolumab for Relapsed Small-Cell Lung Cancer
por: Sarah Maryon Hayes, et al.
Publicado: (2021)

Effect of antibiotic use on the efficacy of nivolumab in the treatment of advanced/metastatic non-small cell lung cancer: A meta-analysis
por: Huo Geng-wei, et al.
Publicado: (2021)

Amifostine- and chemoradiotherapy-related esophagitis in small cell lung cancer: a single institutional series and literature update
por: Pollock AE, et al.
Publicado: (2018)

PELI3 mediates pro-tumor actions of down-regulated miR-365a-5p in non-small cell lung cancer
por: He,Yuzheng, et al.
Publicado: (2019)

Impact of Chronic Obstructive Pulmonary Disease on the Mortality of Patients with Small Cell Lung Cancer
por: Liao KM, et al.
Publicado: (2021)

Small cell transformation in crizotinib‐resistant ROS1‐rearranged non‐small cell lung cancer with retention of ROS1 fusion: A case report
por: Chi‐Hao Wu, et al.
Publicado: (2021)

Small-cell lung cancer growth inhibition: synergism between NMDA receptor blockade and chemotherapy
por: North WG, et al.
Publicado: (2019)

Prognostic characterization of immune molecular subtypes in non-small cell lung cancer to immunotherapy
por: Chenlu Li, et al.
Publicado: (2021)

Prophylactic cranial irradiation in small-cell lung cancer: update on patient selection, efficacy and outcomes
por: Manapov F, et al.
Publicado: (2018)

Clinical case of long-term use of durvalumab in the treatment of advanced small-cell lung cancer
por: Galina B. Statsenko, et al.
Publicado: (2020)

Research on the application of uniportal video-assisted thoracoscopic segmental resection of the lung in elderly patients with non-small cell lung cancer aged over 65 years
por: Hongya Xie, et al.
Publicado: (2021)

Adjuvant targeted therapy for non-small cell lung cancer
por: Konstantin K. Laktionov, et al.
Publicado: (2020)

The association of aspirin use with overall survival of patients with inoperable non-small cell lung cancer: a retrospective study
por: Min-Chun Chuang, et al.
Publicado: (2021)

m6A regulator expression profile predicts the prognosis, benefit of adjuvant chemotherapy, and response to anti-PD-1 immunotherapy in patients with small-cell lung cancer
por: Zhihui Zhang, et al.
Publicado: (2021)

Zebrafish xenograft model for studying mechanism and treatment of non-small cell lung cancer brain metastasis
por: Ruo-Yue Fan, et al.
Publicado: (2021)

Pembrolizumab-Induced Adrenal Insufficiency in Patients with Untreated Advanced Non-Small Cell Lung Cancer: A Case Series
por: Kei Sonehara, et al.
Publicado: (2021)

Treatment of advanced small cell lung cancer. Clinical case and literature review
por: Konstantin V. Menshikov, et al.
Publicado: (2021)

Targeting RET-rearranged non-small-cell lung cancer: future prospects
por: Bronte G, et al.
Publicado: (2019)

Thrombotic Microangiopathy Associated with Gemcitabine in Non-Small Cell Lung Cancer: A Case Report
por: Tadahiro Kuribayashi, et al.
Publicado: (2021)

Significance of radiation esophagitis: Conditional survival assessment in patients with non-small cell lung cancer
por: Hao Yu, et al.
Publicado: (2021)

Mutational signature analysis in non-small cell lung cancer patients with a high tumor mutational burden
por: Guus R. M. van den Heuvel, et al.
Publicado: (2021)

Inhibition of tumor metastasis by targeted daunorubicin and dioscin codelivery liposomes modified with PFV for the treatment of non-small-cell lung cancer
por: Wang Y, et al.
Publicado: (2019)

Detection of disseminated tumor cells and their relationship with a population of bone marrow lymphocytes in patients with non-small cell lung cancer
por: T. M. Djumanazarov, et al.
Publicado: (2020)

Luminal Chemosensory Cells in the Small Intestine
por: Andreanna Burman, et al.
Publicado: (2021)

Pembrolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives
por: Somasundaram A, et al.
Publicado: (2017)

NFAT as a Biomarker and Therapeutic Target in Non–Small Cell Lung Cancer–Related Brain Metastasis
por: Lu Peng, et al.
Publicado: (2021)

Prognostic implication of PD‐L1 polymorphisms in non‐small cell lung cancer treated with radiotherapy
por: Min Kyu Kang, et al.
Publicado: (2021)

Premalignant Changes in the Bronchial Epithelium Are Prognostic Factors of Distant Metastasis in Non-Small Cell Lung Cancer Patients
por: Olga V. Pankova, et al.
Publicado: (2021)

Biogenesis, functions, and clinical implications of circular RNAs in non-small cell lung cancer
por: Ying Liu, et al.
Publicado: (2022)